(MedPage Today) — In the decade since palbociclib (Ibrance) received FDA approval, results from multiple clinical trials have provided a strong evidence base to make cyclin-dependent kinase (CDK)4/6 inhibitors, in combination with endocrine therapy…
‘Ang init ng ulo mo!’: On heat and mental health
How does heat impact our physical and mental well-being? Source: lifestyle.inquirer.net Medical Disclaimer: This content is shared for informational and...






